[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.150.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 8, 1980

HLA-A28 and Steroid-Induced Diabetes in Renal Transplant Patients

Author Affiliations

From the Department of Medicine (Drs David, Cheigh, Stenzel, and Rubin), Rogosin Kidney Center, The New York Hospital-Cornell Medical Center; Biostatistics Laboratory, Memorial Sloan-Kettering Cancer Center (Dr Braun); and New York Blood Center (Dr Fotino); New York.

JAMA. 1980;243(6):532-533. doi:10.1001/jama.1980.03300320024015
Abstract

Between July 1971 and March 1977, steroid-induced diabetes (SD) developed postoperatively in 31 (10.8%) of 286 nondiabetic adult kidney transplant recipients who were observed for a total of 410 patient transplant years. There was a highly significant association between HLA-A28 and SD. There was no significant association between SD and B8 or Bw15. Age was also associated with SD. However, A28 was associated with SD even when corrected for age. A28 occurred more frequently in blacks than whites, 25.4% and 6.3%, respectively, and accounted for the higher incidence of SD in black adults. There were no significant associations between SD and patients' sex, donor source, number of short-term rejection treatments, or maintenance dose of corticosteroids. Steroid-induced diabetes had no adverse effects on graft or patient survival.

(JAMA 243:532-533, 1980)

×